HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

SLC25A19 deficiency and bilateral striatal necrosis with polyneuropathy: a new case and review of the literature.

AbstractOBJECTIVES:
Biallelic mutations in the SLC25A19 gene impair the function of the thiamine mitochondrial carrier, leading to two distinct clinical phenotypes. Homozygosity for the c.530G > C mutation is invariably associated to Amish lethal microcephaly. The second phenotype, reported only in 8 patients homozygous for different non-Amish mutations (c.373G > A, c.580T > C, c.910G > A, c.869T > A, c.576G > C), is characterized by bilateral striatal necrosis and peripheral polyneuropathy. We report a new patient with the non-Amish SLC25A19 phenotype showing compound heterozygosity for the new variant c.673G > A and the known mutation c.373G > A.
CASE PRESENTATION:
The natural history of non-Amish SLC25A19 deficiency is characterized by acute episodes of fever-induced encephalopathy accompanied by isolated lactic acidosis and Leigh-like features at magnetic resonance imaging (MRI). Acute episodes are prevented by high-dose thiamine treatment (600 mg/day). As shown in the new case, both mild clinical signs and basal ganglia involvement can precede the acute encephalopathic onset of the disease, potentially allowing treatment anticipation and prevention of acute brain damage. Peripheral axonal neuropathy, observed in 7 out of 9 patients, is not improved by thiamine therapy. In two early treated patients, however, peripheral neuropathy did not occur even on long-term follow-up, suggesting a potential preventive role of treatment anticipation also at the peripheral level.
CONCLUSIONS:
Non-Amish SLC25A19 deficiency is an extra-rare cause of Leigh syndrome responsive to thiamine treatment. Ex adiuvantibus thiamine treatment is mandatory in any patient with Leigh-like features.
AuthorsFrancesco Porta, Barbara Siri, Nicoletta Chiesa, Federica Ricci, Lulash Nika, Paola Sciortino, Marco Spada
JournalJournal of pediatric endocrinology & metabolism : JPEM (J Pediatr Endocrinol Metab) Vol. 34 Issue 2 Pg. 261-266 (Feb 23 2021) ISSN: 2191-0251 [Electronic] Germany
PMID33544541 (Publication Type: Case Reports, Journal Article, Review)
Copyright© 2020 Walter de Gruyter GmbH, Berlin/Boston.
Chemical References
  • Mitochondrial Membrane Transport Proteins
  • SLC25A19 protein, human
Topics
  • Brain Diseases (complications, pathology)
  • Corpus Striatum (pathology)
  • Humans
  • Infant
  • Male
  • Mitochondrial Membrane Transport Proteins (deficiency, genetics)
  • Mutation
  • Necrosis
  • Phenotype
  • Polyneuropathies (complications, pathology)
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: